CUSIP: 817763105
Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
35,258,228
-
Share change
-
+35,258,228
-
Total reported value
-
$68,754,950
-
Put/Call ratio
-
61%
-
Price per share
-
$1.95
-
Number of holders
-
44
-
Value change
-
+$68,754,950
-
Number of buys
-
44
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 817763105:
Institutional Holders of SESEN BIO INC - COM (SESN) as of Q2 2018
As of 30 Jun 2018,
SESEN BIO INC - COM (SESN) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,258,228 shares.
The largest 10 holders included
Consonance Capital Management LP, venBio Select Advisor LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., DRIEHAUS CAPITAL MANAGEMENT LLC, BAKER BROS. ADVISORS LP, SPHERA FUNDS MANAGEMENT LTD., VANGUARD GROUP INC, BlackRock Inc., Castle Hook Partners LP, and Point72 Asset Management, L.P..
This page lists
44
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.